The core activity of BB Biotech AG is the investment and management of participations in companies from the biotechnology sector. The company focuses on investing in companies that develop innovative medical products and technologies, thereby offering investors the opportunity to participate in the development and success of these companies.
AI-generated
Offering
Products & services
Industry:Funds & Investment CompaniesPrivate Equity & Venture Capital
Outbound Leads by COHAGA
Looking for direct email addresses and phone numbers?
Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.
Listed investment company with permanent capital, focused access to biotechnology innovation, long-term conviction-driven investing, and active portfolio management in biotech companies developing breakthrough drugs.
Biotech portfolio management
Portfolio overview, current holdings, focus areas, concentration and investment approach with research-led stock selection, risk management, and allocation around clinical milestones and strategic outcomes.
Investor relations service
Share information, dividend policy, share buyback, transactions in treasury shares, corporate calendar, annual general meeting information and direct investor contact.
Financial reporting
Annual reports, interim reports, financial statements, factsheets and archive documents with performance, portfolio developments, key figures and disclosures.
Market commentary and company announcements
Articles, videos, expert commentary, media releases and ad hoc releases covering biotech markets, investment thinking and regulatory communications.
Knowledge
No knowledge articles yet
Once BB Biotech AG has claimed this profile, we'll publish editorial articles and case studies here together.